New radionucleotide therapy effective to treat neuroendocrine tumours

26 Jun 2018


A new study in humans, presented during the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, shows that a new, long-lasting radionucleotide therapy is effective for the treatment of advanced metastatic NETs.

Medical Xpress


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story